The amount of data generated, and the type of molecular research conducted has changed drastically over the last two decades. The client was facing the limitations of a traditional Oracle-based on-premises data management. The systems were slow, did not offer much flexibility and scale, high maintenance cost, multiple siloed data sets, and there was not much room for using AI, analytics.
They were looking for a partner to migrate their data to AWS with advanced security features, such as security groups and network access control lists, to enable inbound and outbound filtering.
The challenges the team faced were primarily technical except for a few compliance and clearance, which is expected of a pharma giant.